Vol. 25, No. 2, December 2021

The past, present, and future of IAVI

In conversation with IAVI founder Seth Berkley and CEO Mark Feinberg.

40 years of AIDS vaccine research

A timeline of major milestones in the decades-long effort to develop an HIV vaccine.

What next? HIV science (again) at a turning point

After four decades of HIV research, the field seeks to make progress against one of the most difficult pathogens vaccine researchers have ever faced.

Vaccinology reaches a new peak

Stanley Plotkin discusses the greatest progress in vaccine development in more than half a century and the lingering barriers to an effective HIV vaccine.

The global stakes for vaccine access

COVID-19 has made stark inequities in global access to vaccines, drugs, and diagnostics more visible and alarming than ever.

1 December 2021

The importance of partnerships in accelerating HIV vaccine research and development

Mark Feinberg, Nina Russell, Robin Shattock, Karie Youngdahl

African scientists should lead in developing an Aids jab for Africa

Professor Anatoli Kamali & Dr. Eugene Ruzagira

What can we do differently to help end HIV/AIDS?

Kenneth Katumbe, Ph.D. candidate & research assistant, UPTAKE study, MRC/UVRI & LSHTM Uganda Research Unit

HIV Activist Winifred Ikilai: 5 Things to Know on World AIDS Day 2020

Winifred Ikilai, HIV prevention advocate and public health practitioner, National Forum of People Living with HIV & AIDS Networks, Uganda